95932-32-4

Basic information

• Product Name: Carbonic acid, 1,1-dimethylethyl 3-phenyl-2-propenyl ester, (E)-
• Synonyms: tert-butyl (E)-3-phenylprop-2-en-1-yl carbonate;t-butyl cinnamyl carbonate;tert-butyl cinnamyl carbonate;(E)-cinnamyl tert-butyl carbonate;Carbonic acid tert-butyl ester (E)-3-phenyl-allyl ester;cinnamyl tert-butyl carbonate;(E)-tert-butyl cinnamyl carbonate
• CAS NO: 95932-32-4
• Molecular Formula: C14H18O3
• Molecular Weight: 234.295
• Mol File: 95932-32-4.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 114 °C (2.0252 mmHg)
• Density: 1.051±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Carbonic acid, 1,1-dimethylethyl 3-phenyl-2-propenyl ester, (E)-(CAS DataBase Reference)
• NIST Chemistry Reference: Carbonic acid, 1,1-dimethylethyl 3-phenyl-2-propenyl ester, (E)-(95932-32-4)
• EPA Substance Registry System: Carbonic acid, 1,1-dimethylethyl 3-phenyl-2-propenyl ester, (E)-(95932-32-4)

Safety Data

• Hazardous Substances Data: 95932-32-4(Hazardous Substances Data)

Upstream product

• 100-52-7 benzaldehyde 
• 103-36-6 ethyl 3-phenyl-2-propenoate 
• 104-54-1 3-Phenylpropenol 
• 24424-99-5 di-tert-butyl dicarbonate 
• 4407-36-7 (2E)-3-phenyl-2-propen-1-ol 

Downstream Products

• 99930-72-0 3-[(3-phenyl-(2E)-propenyl)oxy]propylbenzene 
• 14093-65-3 α-phenylallyl ethyl ether 
• 1216911-18-0 2-[(1E,5E)-3,6-diphenyl-1,5-hexadienyl]benzothiazole 
• 133871-12-2 (2S,3R)-diphenyl-4-pentenoic acid methyl ester 

Relevant articles and documents

Ouabain 19-site primary hydroxyl derivative as well as preparation method and application thereof

The invention provides an ouabain 19-site primary hydroxyl derivative as well as a preparation method and application thereof. The structure of the ouabain 19-site primary hydroxyl derivative is shownas a formula I. The derivative has very low toxicity to normal cells and also has an excellent effect of inhibiting tumor cells. In addition, the derivative can effectively inhibit tumor cell migration and invasion. Therefore, the ouabain 19-site primary hydroxyl derivative has a very good application prospect in preparation of drugs for resisting tumors and inhibiting tumor invasion and/or migration.

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AGING-RELATED DISEASES CONTAINING DECURSIN DERIVATIVE AS ACTIVE INGREDIENT

A composition for preventing or treating an aging-related disease includes a novel decursin derivative as an active ingredient, wherein the novel decursin derivative has exhibited an excellent effect of inhibiting progerin expression and excellent effect of inhibiting binding between progerin and lamin A, and it has been confirmed that the novel decursin derivative prolongs the survival period of animal models in which progerin was induced.

Stereodivergent allylic substitutions with aryl acetic acid esters by synergistic iridium and lewis base catalysis

The preparation of all possible stereoisomers of a given chiral molecule bearing multiple stereocenters by a simple and unified method is a significant challenge in asymmetric catalysis. We report stereodivergent allylic substitutions with aryl acetic acid esters catalyzed synergistically by a metallacyclic iridium complex and benzotetramisole. Through permutations of the enantiomers of the two chiral catalysts, all four stereoisomers of the products bearing two adjacent stereocenters are accessible with high diastereoselectivity and enantioselectivity. The resulting chiral activated ester products can be converted readily to enantioenriched amides, unactivated esters, and carboxylic acids in a onepot manner.